共 50 条
- [1] Comparison of Incidence of Acute Myocardial Infarction in Patients With Type 2 Diabetes Mellitus Following Initiation of Neutral Protamine Hagedorn Insulin Versus Insulin Glargine [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2009, 104 (07): : 910 - 916
- [2] Two-year glycaemic control and healthcare expenditures following initiation of insulin glargine versus neutral protamine Hagedorn insulin in type 2 diabetes [J]. DIABETES OBESITY & METABOLISM, 2011, 13 (08): : 711 - 717
- [3] A randomised, open-labelstudy of insulin glargine or neutral protamine Hagedorn insulin in Chinese paediatric patients with type 1 diabetes mellitus [J]. BMC Endocrine Disorders, 16
- [4] A randomised, open-labelstudy of insulin glargine or neutral protamine Hagedorn insulin in Chinese paediatric patients with type 1 diabetes mellitus [J]. BMC ENDOCRINE DISORDERS, 2016, 16 : 67
- [6] Nocturnal glucose metabolism after bedtime injection of insulin glargine or neutral protamine Hagedorn insulin in patients with type 2 diabetes [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2008, 93 (10): : 3839 - 3846
- [8] Long-Term Cost-Effectiveness of Insulin Glargine Versus Neutral Protamine Hagedorn Insulin for Type 2 Diabetes in Thailand [J]. Applied Health Economics and Health Policy, 2016, 14 : 281 - 292
- [10] Modulation of insulin dose titration using a hypoglycaemia-sensitive algorithm: insulin glargine versus neutral protamine Hagedorn insulin in insulin-naive people with type 2 diabetes [J]. DIABETES OBESITY & METABOLISM, 2015, 17 (01): : 15 - 22